Quantcast

Latest Glycated hemoglobin Stories

2014-07-09 08:27:32

Trial to Evaluate Efficacy and Safety of LX4211 in Younger Population THE WOODLANDS, Texas, July 9, 2014 /PRNewswire/ -- Lexicon Pharmaceuticals, Inc. (Nasdaq: LXRX) announced today that JDRF, the world's largest non-profit supporter of type 1 diabetes (T1D) research, will provide funding to support a Phase 2, randomized, double-masked, placebo-controlled clinical trial to evaluate the efficacy and safety of LX4211 in a younger population with T1D. Up to 76 individuals with T1D,...

2014-07-03 11:14:23

Diabetologia A systematic review and meta-analysis of available data published in Diabetologia (the journal of the European Association for the Study of Diabetes) suggests that combined aerobic and resistance training, rather than either alone, is best for controlling both blood sugar and blood fat profiles among people with type 2 diabetes. However the authors stress that the strength of the results is weakened when studies with high risk of bias are removed, and thus more high quality...

2014-07-01 23:02:12

Transparency Market Research has published a new report titled "Hemoglobin A1c Testing Devices Market: Global Analysis, Size, Share, Growth, Trends and Forecast 2013 - 2019" to its report store. Browse the full report: http://www.transparencymarketresearch.com/hemoglobin-a1c-testing.html. Albany, New York (PRWEB) July 01, 2014 According to a new market report published by Transparency Market Research "Hemoglobin A1c Testing Devices Market (End-use-Laboratory and...

2014-06-25 12:29:39

ALBANY, New York, June 25, 2014 /PRNewswire/ -- According to a new market report published by Transparency Market Research "Hemoglobin A1c Testing Devices Market (End-use-Laboratory and Point-of-Care Testing Devices; Technologies - Ion-Exchange HPLC, Immunoassay, Boronate Affinity Chromatography, Direct Enzymatic Assay and Others) - Global Industry Analysis, Size, Share, Growth, Trends and Forecast, 2013 - 2019,"theglobal hemoglobin A1c(HbA1c) testing devices market was...

2014-06-16 16:25:39

Phase 3 Study Results Also Demonstrate INVOKANA® Reduces Secondary Endpoints of Body Weight and Systolic Blood Pressure RARITAN, N.J., June 16, 2014 /PRNewswire/ -- Janssen Research & Development, LLC (Janssen) today announced new results from a 104-week Phase 3 clinical study evaluating the long-term effects of INVOKANA(®) (canagliflozin) in patients aged 55 to 80 years with type 2 diabetes inadequately controlled on current antihyperglycemic therapies. The randomized double-blind...

2014-06-16 13:00:18

St. Michael's Hospital Those on canola bread diet saw both a reduction in blood glucose levels and significant reduction in LDL cholesterol Canola is Canada's oil and new research from St. Michael's Hospital suggests it should also be one of the oils of choice for people with Type 2 diabetes. Dr. David Jenkins, head of the hospital's Clinical Nutrition and Risk Factor Modification Centre, compared people with Type 2 diabetes who ate either a low glycemic index diet that included bread...

2014-06-16 12:29:24

-- In a two-year study, empagliflozin as add-on to metformin demonstrated significantly greater decreases in A1C (blood glucose), body weight and blood pressure compared with glimepiride as add-on to metformin RIDGEFIELD, Conn. and INDIANAPOLIS, June 16, 2014 /PRNewswire/ -- Two phase III clinical trials studying the efficacy and safety of the investigational compound empagliflozin in type 2 diabetes (T2D) were presented today at the American Diabetes Association 74th Scientific Sessions®,...

2014-06-15 16:20:24

- For those taking metformin, empagliflozin/linagliptin combination tablet showed statistically significant reductions in blood glucose vs. empagliflozin or linagliptin alone after 24 weeks RIDGEFIELD, Conn. and INDIANAPOLIS, June 15, 2014 /PRNewswire/ -- Two phase III clinical trials found the investigational combination tablet of empagliflozin and linagliptin reduced blood glucose levels in adults with type 2 diabetes (T2D), Boehringer Ingelheim Pharmaceuticals, Inc. (BIPI) and Eli Lilly...

2014-06-15 15:18:02

The Endocrine Society Study suggests metformin controls blood sugar more effectively in African-Americans African Americans taking the diabetes drug metformin saw greater improvements in their blood sugar control than white individuals who were prescribed the same medication, according to a new study published in the Endocrine Society's Journal of Clinical Endocrinology & Metabolism (JCEM). An estimated 29 million Americans have diabetes. African Americans are twice as likely to...

2014-06-15 08:21:29

-- The average HbA1C reductions in patients treated with ITCA 650 for 6 months at the time of the interim analysis were -3.2%; patients at baseline had HbA1C levels between 10-12%. BOSTON, June 15, 2014 /PRNewswire/ -- Intarcia Therapeutics, Inc. today announced the highlights of a poster presentation at the 74(th) Scientific Sessions of the American Diabetes Association (ADA) held in San Francisco that contained the first 6-month data from an ongoing open-label phase 3 trial...


Word of the Day
mundungus
  • A stinking tobacco.
  • Offal; waste animal product; organic matter unfit for consumption.
This word comes from the Spanish 'mondongo,' tripe, entrails.